Intuitive Surgical (NASDAQ:ISRG) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Intuitive Surgical, Inc. (NASDAQ:ISRG). In a filing disclosed on February 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in Intuitive Surgical stock on January 30th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of ICF International (NASDAQ:ICFI) on 2/3/2025.
• Purchased $15,001 – $50,000 in shares of CACI International (NYSE:CACI) on 1/31/2025.
• Purchased $50,001 – $100,000 in shares of Hawaiian Electric Industries (NYSE:HE) on 1/31/2025.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Agios Pharmaceuticals (NASDAQ:AGIO) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Paragon 28 (NYSE:FNA) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of U.S. Physical Therapy (NYSE:USPH) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 1/29/2025.
• Purchased $1,001 – $15,000 in shares of Lantheus (NASDAQ:LNTH) on 1/28/2025.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $589.61 on Thursday. The firm’s 50-day moving average is $556.91 and its 200-day moving average is $516.98. The stock has a market cap of $210.01 billion, a price-to-earnings ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Analyst Ratings Changes

A number of research analysts recently commented on ISRG shares. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Bernstein Bank upped their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research upped their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently made changes to their positions in ISRG. Atala Financial Inc bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 in the last quarter. Insiders own 0.90% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.